A Randomized Study to Compare the Efficacy and Safety of Belotecan and Topotecan as Monotherapy for Sensitive-Relapsed Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bong Seog Kim, M.D., Ph.D
Seoul Veterans Hospital
Principal Investigator - Chi Hoon Maeng, M.D., Ph.D
Kyung Hee University Medical Hospital
Principal Investigator - Dong-Wan Kim, M.D., Ph.D
Seoul National University Hospital
Principal Investigator - Heung Tae Kim, M.D., Ph.D
National Cancer Center
Principal Investigator - Ho Jung An, M.D., Ph.D
St. Vincents Hospital
Principal Investigator - Hye Ryeon Kim, M.D., Ph.D
Yonsei Cancer Center
Principal Investigator - Jin Hyoung Kang, M.D., Ph.D
The Catholic University of Korea Seoul St. Marys Hospital
Principal Investigator - Jin Hyuk Choi, M.D., Ph.D
Ajou University School of Medicine
Principal Investigator - Jin Young Kim, M.D., Ph.D
Keimyung University Dongsan Medical Center
Principal Investigator - Jin-Soo Kim, M.D., Ph.D
SMG-SNU Boramae Medical Center
Principal Investigator - Joo-Hang Kim, .D., Ph.D
CHA Bundang Medical Center
Principal Investigator - Joung Soon Jang, M.D., Ph.D
Choung Ang University Hospital
Principal Investigator - Ki Hyeong Lee, M.D., Ph.D
Chungbuk National University Hospital
Principal Investigator - Sang-We Kim, M.D., Ph.D
Asan Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chungbuk University Hospital
Daegu, South Korea
- Keimyung University Dongsan Center
Daegu, South Korea
- National Cancer Center
Goyang, South Korea
- Asan Medical Center
Seoul, South Korea
- Cha Bundang Medical Center
Seoul, South Korea
- Chung-Ang University Hospital
Seoul, South Korea
- Kyung Hee University Medical Hospital
Seoul, South Korea
- Seoul National University Boramae Medical Center
Seoul, South Korea
- Seoul National University Hospital
Seoul, South Korea
- Seoul St. Marys Hospital
Seoul, South Korea
- Seoul Veterans Hospital
Seoul, South Korea
- Yonsei Cancer Center
Seoul, South Korea
- Ajou University Hospital
Suwon, South Korea
- St. Vincents Hospital
Suwon, South Korea
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2010
- Primary completion
- 31 Dec 2017
- Completion
- 31 Mar 2018
- Last update posted
- 27 Dec 2018
- Registered enrollment
- 164
- Registry id
- NCT01497873
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.